Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Author Correction: AI based predictive acceptability model for effective vaccine delivery in healthcare systems.

Scientific reports·2025
Same author

Comprehensive Characterization of the Odor-Active Compounds in Different Processed Varieties of Yunnan White Tea (<i>Camellia sinensis</i>) by GC×GC-O-MS and Chemometrics.

Foods (Basel, Switzerland)·2025
Same author

Xylooligosaccharides: A comprehensive review of production, purification, characterization, and quantification.

Food research international (Ottawa, Ont.)·2025
Same author

Correction: Unveiling the obstacles encountered by women doctors in the Pakistani healthcare system: A qualitative investigation.

PloS one·2025
Same author

TargetCLP: clathrin proteins prediction combining transformed and evolutionary scale modeling-based multi-view features via weighted feature integration approach.

Briefings in bioinformatics·2025
Same author

Systematic Review of Vaccine Strategies Against Tritrichomonas foetus Infection in Cattle: Insights, Challenges, and Prospects.

Parasite immunology·2025

Related Experiment Video

Updated: Jul 1, 2025

A Virtual Machine Platform for Non-Computer Professionals for Using Deep Learning to Classify Biological Sequences of Metagenomic Data
09:34

A Virtual Machine Platform for Non-Computer Professionals for Using Deep Learning to Classify Biological Sequences of Metagenomic Data

Published on: September 25, 2021

4.0K

Deepstacked-AVPs: predicting antiviral peptides using tri-segment evolutionary profile and word embedding based

Shahid Akbar1,2, Ali Raza3, Quan Zou4,5

  • 1Institute of Fundamental and Frontier Sciences, University of Electronic Science and Technology of China, Chengdu, 610054, People's Republic of China.

BMC Bioinformatics
|March 8, 2024
PubMed
Summary

This study introduces Deepstacked-AVPs, a machine learning model that accurately identifies antiviral peptides (AVPs). The model offers a faster, more cost-effective alternative to traditional drug discovery methods for viral diseases.

Keywords:
Antiviral peptidesFeature selectionPredictionStacked ensemble modelTri-segmentation based evolutionary featuresWord embedding

More Related Videos

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.0K
Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.0K

Related Experiment Videos

Last Updated: Jul 1, 2025

A Virtual Machine Platform for Non-Computer Professionals for Using Deep Learning to Classify Biological Sequences of Metagenomic Data
09:34

A Virtual Machine Platform for Non-Computer Professionals for Using Deep Learning to Classify Biological Sequences of Metagenomic Data

Published on: September 25, 2021

4.0K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.0K
Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.0K

Area of Science:

  • Computational biology
  • Bioinformatics
  • Drug discovery

Background:

  • Viral infections pose a significant global health challenge.
  • Antiviral peptides (AVPs) show promise as therapeutic agents against viral diseases.
  • Current drug development is costly and time-consuming, necessitating advanced computational approaches.

Purpose of the Study:

  • To develop a novel computational model, Deepstacked-AVPs, for accurate discrimination of antiviral peptides (AVPs).
  • To overcome limitations of existing wet-laboratory methods by leveraging machine learning for AVP identification.
  • To provide a reliable and efficient tool for accelerating the discovery of novel antiviral peptide therapeutics.

Main Methods:

  • Numerical encoding of peptide sequences using Tri-segmentation-based position-specific scoring matrix (PSSM-TS) and word2vec semantic features.
  • Integration of physiochemical properties via Composition/Transition/Distribution-Transition (CTDT) descriptors.
  • Feature selection using Information Gain (IG) and classification with a stacked-ensemble model.

Main Results:

  • The Deepstacked-AVPs model achieved high predictive accuracy (96.60% on training, 95.15% on independent samples).
  • Excellent performance metrics including Area Under the Curve (AUC) of 0.98 and Precision-Recall (PR) of 0.97 were obtained.
  • The model demonstrated superior accuracy compared to existing methods.

Conclusions:

  • Deepstacked-AVPs offers a reliable and effective computational tool for identifying antiviral peptides.
  • The model's performance surpasses existing methods, suggesting its utility in pharmaceutical design and research.
  • This approach can significantly aid in the development of novel antiviral peptide-based drugs.